Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 1.28% vs -30.67% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 49.26% vs -98.38% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 44.73% vs -112.58% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is 8.43% vs 43.10% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of SymBio Pharmaceuticals Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 1.28% vs -30.67% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -38.19% vs -44.28% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 49.26% vs -98.38% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -16.30% vs -37.15% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 44.73% vs -112.58% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -31.38% vs -7.90% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is 8.43% vs 43.10% in Mar 2026
YoY Growth in quarter ended Jun 2026 is -65.12% vs 0.00% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025






